Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Lea Hirsl"'
Autor:
Carmen Rožmanić, Berislav Lisnić, Marina Pribanić Matešić, Andrea Mihalić, Lea Hiršl, Eugene Park, Ana Lesac Brizić, Daniela Indenbirken, Ina Viduka, Marina Šantić, Barbara Adler, Wayne M. Yokoyama, Astrid Krmpotić, Vanda Juranić Lisnić, Stipan Jonjić, Ilija Brizić
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Infections in early life can elicit substantially different immune responses and pathogenesis than infections in adulthood. Here, we investigate the consequences of murine cytomegalovirus infection in newborn mice on NK cells. We show that i
Externí odkaz:
https://doaj.org/article/f7957b6ddb9e405c9a437f4a14f7913c
Autor:
Marko Šustić, Maja Cokarić Brdovčak, Berislav Lisnić, Jelena Materljan, Vanda Juranić Lisnić, Carmen Rožmanić, Daniela Indenbirken, Lea Hiršl, Dirk H. Busch, Ilija Brizić, Astrid Krmpotić, Stipan Jonjić
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Viral vectors have emerged as a promising alternative to classical vaccines due to their great potential for induction of a potent cellular and humoral immunity. Cytomegalovirus (CMV) is an attractive vaccine vector due to its large genome with many
Externí odkaz:
https://doaj.org/article/5fb40c069f0b4c1284e21240e5956e5d
Autor:
Stipan Jonjic, Ofer Mandelboim, Anas Atieh, Akram Obiedat, Guy Cinamon, Tihana Lenac Rovis, Paola Kucan Brlic, Lea Hirsl, Keren Paz, Pini Tsukerman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/e4e7b326de894533a91180eca87bdd91
474 First-in-class anti-PVR mAb NTX1088 restores expression of DNAM1 and augments antitumor immunity
Autor:
Akram Obeidat, Anas Atieh, Alon Vitenshtein, Guy Cinamon, Keren Paz, Tihana Roviš, Paola Brilc, Lea Hirsl, Ofer Mandelboim, Stipan Jonjic, Pini Tsukerman
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Akram Obiedat, Anas Atieh, Guy Cinamon, Keren Paz, Paola Kucan Brilc, Lea Hirsl, Tihana Lenac Roviš, Ofer Mandelboim, Stipan Jonjic, Pini Tsukerman
Publikováno v:
Cancer Research. 82:5534-5534
Poliovirus receptor (PVR, CD155), expressed on the surface of cancer cells, represents a resistance mechanism to approved immune checkpoint inhibitors (ICIs). It is a key regulator of immune activation, that modifies function through multiple mechani
Autor:
Pini Tsukerman, Anas Atieh, Akram Obeidat, Keren Paz, Guy Cinamon, Tihana Lenac Rovis, Paola Kucan Brlic, Lea Hirsl, Stipan Jonjić, Ofer Mandelboim
Publikováno v:
Cancer Immunology Research. 10:P075-P075
The poliovirus receptor (PVR, CD155) represents a resistance mechanism to approved immune checkpoint inhibitors (ICIs). It is a key regulator of immune activation, that modifies immune function through multiple mechanisms. Increased levels of PVR exp
Autor:
Pini Tsukerman, Anas Atieh, Akram Obeidat, Keren Paz, Guy Cinamon, Tihana Lenac Roviš, Lea Hirsl, Paola Kucan Brilc, Stipan Jonjic, Ofer Mandelboim
Publikováno v:
Molecular Cancer Therapeutics. 20:P102-P102
The poliovirus receptor (PVR, CD155) represents a resistance mechanism to approved immune checkpoint inhibitors (ICIs). It is a key regulator of immune activation, that modifies immune function through multiple mechanisms. Increased levels of PVR exp
Publikováno v:
Viruses, Vol 13, Iss 12, p 2481 (2021)
There is a large unmet need for a prophylactic vaccine against human cytomegalovirus (HCMV) to combat the ubiquitous infection that is ongoing with this pathogen. A vaccination against HCMV could protect immunocompromised patients and prevent birth d
Externí odkaz:
https://doaj.org/article/120778f52f254d9c8f957f032e8e9c9b
Autor:
Lea Hiršl, Ilija Brizić, Tina Jenuš, Vanda Juranić Lisnić, Johanna Julia Reichel, Slaven Jurković, Astrid Krmpotić, Stipan Jonjić
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
The development of a vaccine against human cytomegalovirus (CMV) has been a subject of long-term medical interest. The research during recent years identified CMV as an attractive vaccine vector against infectious diseases and tumors. The immune resp
Externí odkaz:
https://doaj.org/article/9ecfac6b25e3403b9ec097663a5690bb